434 related articles for article (PubMed ID: 29138281)
1. A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations
Bardai FH; Wang L; Mutreja Y; Yenjerla M; Gamblin TC; Feany MB
J Neurosci; 2018 Jan; 38(1):108-119. PubMed ID: 29138281
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of dMyc mitigates Tau
Pragati ; Chanu SI; Sarkar S
Neurosci Lett; 2020 Jan; 715():134622. PubMed ID: 31715291
[TBL] [Abstract][Full Text] [Related]
3. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
5. P301 L, an FTDP-17 Mutant, Exhibits Enhanced Glycation in vitro.
Sonawane SK; Chinnathambi S
J Alzheimers Dis; 2020; 75(1):61-71. PubMed ID: 32250308
[TBL] [Abstract][Full Text] [Related]
6. Familial FTDP-17 missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro.
Han D; Qureshi HY; Lu Y; Paudel HK
J Biol Chem; 2009 May; 284(20):13422-13433. PubMed ID: 19304664
[TBL] [Abstract][Full Text] [Related]
7. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells.
Vogelsberg-Ragaglia V; Bruce J; Richter-Landsberg C; Zhang B; Hong M; Trojanowski JQ; Lee VM
Mol Biol Cell; 2000 Dec; 11(12):4093-104. PubMed ID: 11102510
[TBL] [Abstract][Full Text] [Related]
8. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
[TBL] [Abstract][Full Text] [Related]
9. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J
Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044
[TBL] [Abstract][Full Text] [Related]
10. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
11. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
12. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
13. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Strang KH; Golde TE; Giasson BI
Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
[TBL] [Abstract][Full Text] [Related]
14. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila.
Blard O; Feuillette S; Bou J; Chaumette B; Frébourg T; Campion D; Lecourtois M
Hum Mol Genet; 2007 Mar; 16(5):555-66. PubMed ID: 17309878
[TBL] [Abstract][Full Text] [Related]
15. Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells.
Mack TG; Dayanandan R; Van Slegtenhorst M; Whone A; Hutton M; Lovestone S; Anderton BH
Neuroscience; 2001; 108(4):701-12. PubMed ID: 11738505
[TBL] [Abstract][Full Text] [Related]
16. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
17. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
18. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
[TBL] [Abstract][Full Text] [Related]
19. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
[TBL] [Abstract][Full Text] [Related]
20. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.
Hong M; Zhukareva V; Vogelsberg-Ragaglia V; Wszolek Z; Reed L; Miller BI; Geschwind DH; Bird TD; McKeel D; Goate A; Morris JC; Wilhelmsen KC; Schellenberg GD; Trojanowski JQ; Lee VM
Science; 1998 Dec; 282(5395):1914-7. PubMed ID: 9836646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]